documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
- comment_end_date
- A FULL UTC INSTANT, not a calendar date, despite the column name: '2026-08-29T03:59:59Z' is 11:59:59 PM EASTERN on 2026-08-28. Federal comment periods close at 11:59:59 PM Eastern, so the UTC calendar date is ONE DAY LATER than the official deadline on every end-of-day close — 444,689 of the 444,690 populated rows (measured 2026-09-06). Convert to America/New_York before presenting a deadline, and compare with julianday(comment_end_date) > julianday('now'): a plain > datetime('now') is a TEXT comparison between two different formats and keeps already-closed dockets matching for up to ~20 hours. The sibling column on open_comments.documents WAS corrected to an Eastern calendar date (queue #498); this one is unchanged and still an instant — the two databases do not agree on grain. (queue #644)
- comment_start_date
- A FULL UTC INSTANT, not a calendar date, despite the column name — same grain as comment_end_date on this table. Convert to America/New_York before presenting it. (queue #644)
7,453 rows where agency_id = "FDA" and posted_year = 2013 sorted by posted_date descending
This data as json, CSV (advanced)
document_type 5
- Other 6,331
- Notice 718
- Supporting & Related Material 222
- Proposed Rule 107
- Rule 75
posted_year 1
- 2013 · 7,453 ✖
agency_id 1
- FDA · 7,453 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-V-1596-0001 | FDA | Laser Light Show FDA-2013-V-1596 | Duality- Application for Variance | Other | Application for Variance (VAR) | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2013-12-31T18:19:11Z | 0 | 0 | 09000064814b23ab | ||
| FDA-1979-N-0409-0001 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Blood and Blood Components; Error and Accident Reports - Notice of Proposed Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 1980-11-07T04:59:59Z | 2014-05-08T14:18:07Z | 0 | 0 | 090000648055636a | |
| FDA-1979-N-0409-0003 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Regulatory Analysis Assessment for Proposed Rule Making for Blood and Blood Components Concerning Error and Accident Reports - Regulatory Analysis | Supporting & Related Material | Regulatory Analysis | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T15:35:10Z | 0 | 0 | 09000064814e3e84 | |||
| FDA-2011-N-0922-0017 | FDA | Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food For Animals FDA-2011-N-0922 | Request for Extension from American Feed Industry Association | Other | Request for Extension | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2013-12-31T19:44:06Z | 0 | 0 | 0900006481492bbf | ||
| FDA-1979-N-0409-0002 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Regulatory Analysis Assessment for Proposed Rule Making for Blood and Blood Components Concerning Error and Accident Reports - Regulatory Analysis | Supporting & Related Material | Regulatory Analysis | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T15:28:51Z | 0 | 0 | 0900006480556369 | |||
| FDA-2013-V-1595-0001 | FDA | Laser Light Show FDA-2013-V-1595 | Create Nightclub - Application for Variance | Other | Application for Variance (VAR) | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2013-12-31T18:24:52Z | 0 | 0 | 09000064814b34bd | ||
| FDA-1979-N-0028-0035 | FDA | Lakes of Color Additives FDA-1979-N-0028 | Supplement from Colorcon | Supporting & Related Material | Supplement | 2013-12-31T05:00:00Z | 2013 | 12 | 2014-05-14T14:37:03Z | 0 | 0 | 0900006480553999 | |||
| FDA-1979-N-0028-0036 | FDA | Lakes of Color Additives FDA-1979-N-0028 | Letter from SunChemical Corporation to FDA Dated March 20 1997 | Other | Letter(s) | 2013-12-31T05:00:00Z | 2013 | 12 | 1998-04-15T04:00:00Z | 2015-04-01T19:48:32Z | 0 | 0 | 090000648055399b | ||
| FDA-1979-N-0409-0020 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-09T14:38:20Z | 0 | 0 | 090000648055637d | |
| FDA-2013-V-1596-0002 | FDA | Laser Light Show FDA-2013-V-1596 | Acknowledgement Letter to Duality | Other | Acknowledgement Letter/Receipt | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2013-12-31T18:19:19Z | 0 | 0 | 09000064814b34bb | ||
| FDA-2013-V-1595-0002 | FDA | Laser Light Show FDA-2013-V-1595 | Acknowledgement Letter to Create Nightclub | Other | Acknowledgement Letter/Receipt | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2013-12-31T18:25:02Z | 0 | 0 | 09000064814b34bf | ||
| FDA-1979-N-0409-0021 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-05-09T14:38:40Z | 0 | 0 | 090000648055637e | ||
| FDA-2013-N-1317-0092 | FDA | Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information FDA-2013-N-1317 | Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information; Extension of Comment Period | Notice | Extension of Comment Period | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-03-09T04:59:59Z | 2015-06-20T01:30:52Z | 2013-31294 | 0 | 0 | 09000064814e42b9 |
| FDA-2013-N-1634-0001 | FDA | Request for Notification from Industry Organizations Interested in Participating in Selection Process for a Nonvoting Industry Representative on the Food Advisory Committee and Request for Nominations for a Nonvoting Industry Representative on the Food Advisory Committee FDA-2013-N-1634 | Request for Notification From Industry Organizations Interested in Participating in Selection Process for a Nonvoting Industry Representative on the Food Advisory Committee and Request for Nominations for a Nonvoting Industry Representative on the Food Advisory Committee | Notice | General Notice | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-01-02T14:51:51Z | 2013-31321 | 0 | 0 | 09000064814e428c | |
| FDA-2013-N-0001-0120 | FDA | Advisory Committee, Workshops & Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc) FDA-2013-N-0001 | Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-01-02T15:01:22Z | 2013-31320 | 0 | 0 | 09000064814e431a | |
| FDA-2013-V-1607-0001 | FDA | Laser Light Show FDA-2013-V-1607 | DJ Leo Entertainment - Application for Variance | Other | Application for Variance (VAR) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:50:09Z | 0 | 0 | 09000064814baabb | ||
| FDA-2013-V-1608-0002 | FDA | Laser Light Show FDA-2013-V-1608 | Acknowledgement Letter to Nu-Salt | Other | Acknowledgement Letter/Receipt | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:10:14Z | 0 | 0 | 09000064814ba667 | ||
| FDA-1980-N-0149-0002 | FDA | Platelet Concentrate & Cryoprecipitated Anthihemophilic - CLOSED FDA-1980-N-0149 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-08T12:59:27Z | 0 | 0 | 09000064805bcf63 | |
| FDA-1979-N-0309-0003 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-12T14:04:10Z | 0 | 0 | 09000064805551a5 | ||
| FDA-1980-N-0149-0003 | FDA | Platelet Concentrate & Cryoprecipitated Anthihemophilic - CLOSED FDA-1980-N-0149 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-08T13:00:01Z | 0 | 0 | 09000064805bcf64 | ||
| FDA-2013-P-1611-0002 | FDA | Amend two Regulations Within The Code of Federal Regulations, Title 21 - Food and Drugs, Chapter 1, Supchapter H- Medical Devices, Part 872- Dental Devices (Subpart D-Prosthetic Devices 872.3690 - Tooth Shade Resin Material and Subpart G-Miscellaneous Devices 872.6070 - Ultraviolet Activator for Polymerization) to Include Special Controls Guidance FDA-2013-P-1611 | Acknowledgement Letter to Clarissa Clarke | Other | Acknowledgement Letter/Receipt | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2024-07-25T12:19:07Z | 0 | 0 | 09000064814ba8c7 | ||
| FDA-2013-N-1676-0001 | FDA | International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Tapentadol; N-benzylpiperazine (BZP); gamma-Butyrolactone (GBL); 1,4-Butanediol (I,4 BD); (1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-018); (1-butyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-073); [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone; Request for Comments FDA-2013-N-1676 | International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Tapentadol; Tramadol; Ketamine; gamma-Butyrolactone; 22 Additional Substances; Request for Comments | Notice | Request for Comments | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-01-30T04:59:59Z | 2024-11-07T23:00:25Z | 2013-31212 | 1 | 0 | 09000064814e192b |
| FDA-2013-V-1599-0001 | FDA | Laser Light Show FDA-2013-V-1599 | The Living Room - Application for Variance | Other | Application for Variance (VAR) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:58:50Z | 0 | 0 | 09000064814b6fb0 | ||
| FDA-2013-V-1599-0002 | FDA | Laser Light Show FDA-2013-V-1599 | Acknowledgement Letter to The Living Room | Other | Acknowledgement Letter/Receipt | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:58:51Z | 0 | 0 | 09000064814b6ff2 | ||
| FDA-2013-N-0002-0045 | FDA | NADA/ANADA Notices FDA-2013-N-0002 | New Animal Drugs for Use in Animal Feeds; Bambermycins; Correction | Rule | Correction | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:28:01Z | 2013-31184 | 0 | 0 | 09000064814e1974 | |
| FDA-1979-N-0307-0001 | FDA | Allergenic Extract Labeling - CLOSED FDA-1979-N-0307 | Allergenic Products; Proposed Testing and Labeling Requirements; Proposed Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1980-07-02T03:59:59Z | 2014-06-18T16:36:34Z | 0 | 0 | 090000648055517f | |
| FDA-1979-N-0028-0014 | FDA | Lakes of Color Additives FDA-1979-N-0028 | Comment from Colorcon, Inc. re FDA-1979-N-0028-0040 | Supporting & Related Material | Background Material | 2013-12-30T05:00:00Z | 2013 | 12 | 2015-02-13T18:50:40Z | 0 | 0 | 0900006480553968 | |||
| FDA-1979-N-0084-0002 | FDA | Food Labeling; Net Weight Labeling Requirements-CLOSED FDA-1979-N-0084 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-12T18:35:27Z | 0 | 0 | 0900006480553e83 | |
| FDA-1979-N-0309-0001 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Additional Standards for Human Blood Products; Antihemophillic Factor (Human) - Notice of Proposed Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-13T14:33:51Z | 0 | 0 | 090000648055519b | ||
| FDA-1979-N-0084-0001 | FDA | Food Labeling; Net Weight Labeling Requirements-CLOSED FDA-1979-N-0084 | Food Labeling; Net Weight Labeling Requirements - Notice of Proposed Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1980-11-07T04:59:59Z | 2014-05-12T18:31:25Z | 0 | 0 | 0900006480553e82 | |
| FDA-2012-N-1239-0004 | FDA | Dental Devices; Reclassification of Temporary Mandibular Condyle Prosthesis - CLOSED FDA-2012-N-1239 | Dental Devices; Reclassification of Temporary Mandibular Condyle Prosthesis | Rule | Final Rule | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:21:52Z | 2013-31217 | 0 | 0 | 09000064814e1b8c | |
| FDA-2013-V-1607-0002 | FDA | Laser Light Show FDA-2013-V-1607 | Acknowledgement Letter to DJ Leo Entertainment | Other | Acknowledgement Letter/Receipt | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:50:09Z | 0 | 0 | 09000064814baabd | ||
| FDA-2013-V-1608-0001 | FDA | Laser Light Show FDA-2013-V-1608 | Nu-Salt - Application for Variance | Other | Application for Variance (VAR) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:10:13Z | 0 | 0 | 09000064814ba665 | ||
| FDA-2013-N-0581-0002 | FDA | Cardiovascular Devices; Reclassification of Intra-Aortic Balloon and Control Systems for Acute Coronary Syndrome, Cardiac and Non-Cardiac Surgery or Complications of Heart Failure; Effective Date of Requirement for Premarket Approval for Intra-Aortic Balloon and Control Systems for Septic Shock or Pulsatile Flow Generation - CLOSED FDA-2013-N-0581 | Cardiovascular Devices; Reclassification of Intra-Aortic Balloon and Control Systems for Acute Coronary Syndrome, Cardiac and Non- Cardiac Surgery, or Complications of Heart Failure; Effective Date of Requirement for Premarket Approval for Intra-Aortic Balloon and Control Systems for Septic Shock or Pulsatile Flow Generation | Rule | Final Rule | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:52:49Z | 2013-31218 | 0 | 0 | 09000064814e1976 | |
| FDA-2013-P-1609-0001 | FDA | Determine Whether the two-Vial Container Closure System That was Previously Used to Package the Following Lupron Depot (Leuprolide Acetate for Depot Suspension) Injection Drug Products was Voluntarily Withdrawn From Sale for Safety or Efficacy FDA-2013-P-1609 | Lachman Consultant Services, Inc. - Citizen Petition | Other | Citizen Petition | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2024-11-07T22:59:08Z | 1 | 0 | 09000064814ba5ba | ||
| FDA-2013-N-1155-0002 | FDA | Food Labeling Regulations FDA-2013-N-1155 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food Labeling Regulations | Notice | General Notice | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-01-30T04:59:59Z | 2014-01-25T02:04:00Z | 2013-31215 | 0 | 0 | 09000064814e19fd |
| FDA-2013-N-0001-0119 | FDA | Advisory Committee, Workshops & Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc) FDA-2013-N-0001 | Strategies To Address Hemolytic Complications of Immune Globulin Infusions; Public Workshop | Notice | Public Meetings | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:17:54Z | 2013-31213 | 0 | 0 | 09000064814e18f0 | |
| FDA-2013-P-1623-0001 | FDA | Refuse to Receive any ANDA for Asenapine Maleate Sublingual Tablets That Does not Contain the Results of a Bioequivalence Study Performed; Requests That the Fling Acceptance Date of any ANDA for Asenapine Sublingual Tablets be Based on the Date That the Application First Contained the Results of a Bioequivalence Study FDA-2013-P-1623 | Sigmapharm Laboratories, LLC - Citizen Petition | Other | Citizen Petition | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2019-07-08T13:35:40Z | 0 | 0 | 09000064814bd194 | ||
| FDA-2013-N-0487-0004 | FDA | Cardiovascular Devices; Reclassification of External Counter-Pulsating Devices for Treatment of Chronic Stable Angina That Is Refractory to Optimal Antianginal Medical Therapy and Without Options for Revascularization; Effective Date of Requirement for Premarket Approval for External Counter-Pulsating Devices for Other Specified Intended Uses - CLOSED FDA-2013-N-0487 | Cardiovascular Devices; Reclassification of External Counter- Pulsating Devices for Treatment of Chronic Stable Angina; Effective Date of Requirement for Premarket Approval for External Counter- Pulsating Devices for Other Specified Intended Uses | Rule | Final Rule | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:58:02Z | 2013-31216 | 0 | 0 | 09000064814e1adf | |
| FDA-1979-N-0307-0003 | FDA | Allergenic Extract Labeling - CLOSED FDA-1979-N-0307 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Withdrawal of Proposed Rule | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T18:42:25Z | 0 | 0 | 0900006480555185 | ||
| FDA-1979-N-0309-0011 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Background Material Items 4 and 5; Appendices I through V | Supporting & Related Material | Background Material | 2013-12-30T05:00:00Z | 2013 | 12 | 2014-05-12T15:05:06Z | 0 | 0 | 0900006480555199 | |||
| FDA-1979-N-0309-0012 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Background Material items 1 and 2 | Supporting & Related Material | Environmental Impact Analysis Report | 2013-12-30T05:00:00Z | 2013 | 12 | 2014-05-12T15:18:55Z | 0 | 0 | 0900006480555198 | |||
| FDA-1979-N-0309-0010 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Background Material Items 2 and 3 | Supporting & Related Material | Regulatory Analysis | 2013-12-30T05:00:00Z | 2013 | 12 | 2014-05-12T14:42:31Z | 0 | 0 | 090000648055519a | |||
| FDA-1979-N-0307-0004 | FDA | Allergenic Extract Labeling - CLOSED FDA-1979-N-0307 | Regulatory Analysis Assessment for Proposed Rule Making Concerning Allergenic Products - Regulatory Assessment | Supporting & Related Material | Regulatory Analysis | 2013-12-30T05:00:00Z | 2013 | 12 | 2014-05-14T13:06:09Z | 0 | 0 | 090000648055517d | |||
| FDA-2013-P-1623-0002 | FDA | Refuse to Receive any ANDA for Asenapine Maleate Sublingual Tablets That Does not Contain the Results of a Bioequivalence Study Performed; Requests That the Fling Acceptance Date of any ANDA for Asenapine Sublingual Tablets be Based on the Date That the Application First Contained the Results of a Bioequivalence Study FDA-2013-P-1623 | Acknowledgement Letter to Sigmapharm Laboratories LLC | Other | Acknowledgement Letter/Receipt | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T16:12:16Z | 0 | 0 | 09000064814bd198 | ||
| FDA-1980-N-0149-0009 | FDA | Platelet Concentrate & Cryoprecipitated Anthihemophilic - CLOSED FDA-1980-N-0149 | Proposed Rule - Quality Control Testing of Platelet Concentrate (Human) and Cryoprecipitated Antihemophilic Factor (Human) - Regulatory Analysis Assessment | Supporting & Related Material | Regulatory Analysis | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T18:35:48Z | 0 | 0 | 09000064805bcf5c | |||
| FDA-2013-N-1425-0003 | FDA | Focused Mitigation Strategies to Protect Food Against Intentional Adulteration FDA-2013-N-1425 | List of References From PRIA Reference 65 | Other | List (LST) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:09:49Z | 0 | 0 | 09000064814e179f | ||
| FDA-1979-N-0307-0002 | FDA | Allergenic Extract Labeling - CLOSED FDA-1979-N-0307 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2013-12-30T18:42:24Z | 0 | 0 | 0900006480555184 | |
| FDA-1980-N-0149-0001 | FDA | Platelet Concentrate & Cryoprecipitated Anthihemophilic - CLOSED FDA-1980-N-0149 | Withdrawal of Certain Pre-1986 Proposed Rules - Notice of Proposed Rulemaking | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-08T12:45:51Z | 0 | 0 | 09000064805bcf5d | ||
| FDA-2013-P-1609-0002 | FDA | Determine Whether the two-Vial Container Closure System That was Previously Used to Package the Following Lupron Depot (Leuprolide Acetate for Depot Suspension) Injection Drug Products was Voluntarily Withdrawn From Sale for Safety or Efficacy FDA-2013-P-1609 | Acknowledgement Letter to Lachman Consultant Services, Inc. | Other | Citizen Petition | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T16:00:10Z | 0 | 0 | 09000064814ba662 | ||
| FDA-1979-N-0084-0004 | FDA | Food Labeling; Net Weight Labeling Requirements-CLOSED FDA-1979-N-0084 | Memorandum from FDA CFSAN to DDM | Other | Memorandum | 2013-12-30T05:00:00Z | 2013 | 12 | 2014-05-12T18:38:57Z | 0 | 0 | 0900006480553e85 | |||
| FDA-1979-N-0084-0003 | FDA | Food Labeling; Net Weight Labeling Requirements-CLOSED FDA-1979-N-0084 | Food Labeling; Net Weight Labeling Requirements - Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-12T18:35:45Z | 0 | 0 | 0900006480553e84 | ||
| FDA-1979-N-0309-0002 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-12T14:03:52Z | 0 | 0 | 09000064805551a4 | |
| FDA-2013-P-1611-0001 | FDA | Amend two Regulations Within The Code of Federal Regulations, Title 21 - Food and Drugs, Chapter 1, Supchapter H- Medical Devices, Part 872- Dental Devices (Subpart D-Prosthetic Devices 872.3690 - Tooth Shade Resin Material and Subpart G-Miscellaneous Devices 872.6070 - Ultraviolet Activator for Polymerization) to Include Special Controls Guidance FDA-2013-P-1611 | Citizen Petition from Clarissa Clarke | Other | Citizen Petition | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2024-07-25T12:18:51Z | 0 | 0 | 09000064814ba6d2 | ||
| FDA-1977-N-0005-0367 | FDA | New Animal Drugs for use in Animal Feeds FDA-1977-N-0005 | FDA/Office of Legislative Affairs to Hess & Clark, Inc. - Answer | Other | Answer | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2013-12-27T15:16:38Z | 0 | 0 | 09000064805d7d65 | ||
| FDA-2013-N-0002-0049 | FDA | NADA/ANADA Notices FDA-2013-N-0002 | Approvals of New Animal Drug Applications Withdrawals Roxarsone | Rule | Final Rule | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-01-25T23:25:40Z | 2013-30837 | 0 | 0 | 09000064814de405 | |
| FDA-2013-N-0002-0044 | FDA | NADA/ANADA Notices FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Roxarsone | Rule | Final Rule | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2013-12-27T15:39:48Z | 2013-30838 | 0 | 0 | 09000064814de527 | |
| FDA-2011-P-0438-0006 | FDA | Ban the marketing of, and recall Bedside Assistant® bed handles manufactured by Bed Handles Inc, models BA10W and A10W-6 FDA-2011-P-0438 | FDA/CDRH Response to Public Citizen Health Research Group - Partial Petition Approval and Denial | Other | Partial Petition Approval and Denial | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2013-12-27T12:55:24Z | 0 | 0 | 09000064814ddf89 | ||
| FDA-2013-N-0500-0006 | FDA | Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products FDA-2013-N-0500 | Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Correction and Extension of Comment Period | Proposed Rule | Extension of Comment Period | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-03-14T03:59:59Z | 2014-04-10T01:02:03Z | 2013-30881 | 0 | 0 | 09000064814debad |
| FDA-1977-N-0005-0357 | FDA | New Animal Drugs for use in Animal Feeds FDA-1977-N-0005 | Definitions and General Considerations; Revised Procedures re Medicated Feed Applications - Notice of Extension of Comment Period | Notice | Notice of Extension | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 1981-07-09T03:59:59Z | 2013-12-27T14:11:12Z | 0 | 0 | 09000064805d7b84 | |
| FDA-2013-N-1147-0002 | FDA | Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition FDA-2013-N-1147 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition | Notice | General Notice | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-01-28T04:59:59Z | 2013-12-27T15:48:56Z | 2013-30998 | 0 | 0 | 09000064814de952 |
| FDA-2011-N-0179-0019 | FDA | Information Required in Prior Notice of Imported Food FDA-2011-N-0179 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 | Notice | General Notice | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-01-28T04:59:59Z | 2014-04-04T17:00:53Z | 2013-30996 | 0 | 0 | 09000064814deaed |
| FDA-2013-N-1558-0001 | FDA | Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products re FDA-2010-D-0635 FDA-2013-N-1558 | Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products | Notice | 60 Day Proposed Information Collection | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-02-26T04:59:59Z | 2015-02-14T00:29:34Z | 2013-30880 | 0 | 0 | 09000064814debdd |
| FDA-1977-N-0005-0385 | FDA | New Animal Drugs for use in Animal Feeds FDA-1977-N-0005 | FDA/Office of Legislative Affairs to Cooper Evans - Answer | Other | Answer | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2013-12-27T16:52:54Z | 0 | 0 | 09000064805d7d66 | ||
| FDA-1977-N-0005-0366 | FDA | New Animal Drugs for use in Animal Feeds FDA-1977-N-0005 | Department of Health & Human Services, Public Health Service, Region 5 - Letter | Other | Letter(s) | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2013-12-27T15:11:24Z | 0 | 0 | 09000064805d7b8f | ||
| FDA-2013-N-1620-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Information From United States Firms and Processors That Export to the European Community FDA-2013-N-1620 | Agency Information Collection Activities; Proposed Collection; Comment Request; Information From United States Firms and Processors That Export to the European Community | Notice | General Notice | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-02-25T04:59:59Z | 2024-11-07T23:00:22Z | 2013-30804 | 1 | 0 | 09000064814dcb64 |
| FDA-2013-M-1605-0001 | FDA | Premarket Approval FDA-2013-M-1605 | Premarket Approval of W.L. Gore and Associates, Inc. P130006 | Other | Approval | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T15:12:16Z | 0 | 0 | 09000064814dab0f | ||
| FDA-2013-E-1694-0002 | FDA | Patent Extension Application for TriVascular Ovation Abdominal Stent Graft System, Patent No. 6,395,019 FDA-2013-E-1694 | TriVascular, Inc. - Patent Term Application | Other | Application | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T17:49:36Z | 0 | 0 | 09000064814dd643 | ||
| FDA-2013-E-1694-0001 | FDA | Patent Extension Application for TriVascular Ovation Abdominal Stent Graft System, Patent No. 6,395,019 FDA-2013-E-1694 | U.S. Patant and Trademark Office - Letter | Other | Letter(s) | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T17:49:28Z | 0 | 0 | 09000064814dd644 | ||
| FDA-2013-E-1691-0001 | FDA | Patent Extension Application for KADCYLA™ Patent No. 8,337,856 FDA-2013-E-1691 | U.S.. Patatent and Trademark Office - Letter | Other | Letter(s) | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T14:10:36Z | 0 | 0 | 09000064814dc7e9 | ||
| FDA-2013-D-1566-0002 | FDA | Naming of Drug Products Containing Salt Drug Substances FDA-2013-D-1566 | Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances | Other | Guidance | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2024-11-07T23:00:18Z | 1 | 0 | 09000064814dcd46 | ||
| FDA-2013-N-0001-0118 | FDA | Advisory Committee, Workshops & Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc) FDA-2013-N-0001 | Allergenic Products Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T14:51:40Z | 2013-30799 | 0 | 0 | 09000064814dc88e | |
| FDA-2013-E-1692-0001 | FDA | Patent Extension Application for KADCYLA™ Patent No. 7,097,840 FDA-2013-E-1692 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T14:45:07Z | 0 | 0 | 09000064814dc7ee | ||
| FDA-2013-E-0296-0003 | FDA | Patent Extension Application for COFLEX U.S. Patent No. 5,645,599 FDA-2013-E-0296 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T15:48:59Z | 0 | 0 | 09000064814dcd48 | ||
| FDA-2013-N-1618-0001 | FDA | Draft Prescription Drug User Fee Act V Information Technology Plan FDA-2013-N-1618 | Draft Prescription Drug User Fee Act V Information Technology Plan; Availability for Comment | Notice | General Notice | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-02-25T04:59:59Z | 2024-11-07T23:00:00Z | 2013-30818 | 1 | 0 | 09000064814dc9f4 |
| FDA-1977-N-0005-0329 | FDA | New Animal Drugs for use in Animal Feeds FDA-1977-N-0005 | FDA/Office of Legislative Affairs to the Honorable Paul Findley - Comment | Other | Answer | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T18:05:15Z | 0 | 0 | 09000064805d7d64 | ||
| FDA-2013-E-1691-0002 | FDA | Patent Extension Application for KADCYLA™ Patent No. 8,337,856 FDA-2013-E-1691 | Morrison & Foerster LLP (on behalf of Genenetech, Inc) - Patent Term Application | Other | Application | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T14:27:36Z | 0 | 0 | 09000064814db700 | ||
| FDA-2013-E-1690-0002 | FDA | Patent Extension Application for SYNRIBO®, Patent No. 6,987,103 FDA-2013-E-1690 | CEPHALON, Inc. - Patent Term Application | Other | Application | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T13:38:09Z | 0 | 0 | 09000064814db6fc | ||
| FDA-2013-E-1692-0002 | FDA | Patent Extension Application for KADCYLA™ Patent No. 7,097,840 FDA-2013-E-1692 | Morrison & Foerster LLP (on behalf of Genenetech, Inc) - Patent Term Application | Other | Application | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T14:45:22Z | 0 | 0 | 09000064814dc7ed | ||
| FDA-2013-N-1615-0002 | FDA | Draft Generic Drug User Fee Act Information Technology Plan; Availability for Comment FDA-2013-N-1615 | 16452 GDUFA IT Plan | Supporting & Related Material | Background Material | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T16:58:52Z | 0 | 0 | 09000064814dd570 | |||
| FDA-2013-D-1566-0001 | FDA | Naming of Drug Products Containing Salt Drug Substances FDA-2013-D-1566 | Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances; Availability | Notice | Notice of Availability | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-03-27T03:59:59Z | 2014-03-27T01:02:38Z | 2013-30800 | 0 | 0 | 09000064814dcb61 |
| FDA-2013-E-1690-0001 | FDA | Patent Extension Application for SYNRIBO®, Patent No. 6,987,103 FDA-2013-E-1690 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T13:38:00Z | 0 | 0 | 09000064814db6fd | ||
| FDA-2013-N-1618-0002 | FDA | Draft Prescription Drug User Fee Act V Information Technology Plan FDA-2013-N-1618 | 16451 PDUFA IT Plan | Supporting & Related Material | Background Material | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T17:04:34Z | 0 | 0 | 09000064814dd571 | |||
| FDA-2013-N-1615-0001 | FDA | Draft Generic Drug User Fee Act Information Technology Plan; Availability for Comment FDA-2013-N-1615 | Draft Generic Drug User Fee Act Information Technology Plan; Availability for Comment | Notice | General Notice | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-02-25T04:59:59Z | 2014-02-25T02:03:09Z | 2013-31008 | 0 | 0 | 09000064814dcba6 |
| FDA-2013-N-0001-0117 | FDA | Advisory Committee, Workshops & Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc) FDA-2013-N-0001 | Science Advisory Board to the National Center for Toxicological Research; Notice of Meeting | Notice | Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T14:55:25Z | 2013-30578 | 0 | 0 | 09000064814d558a | |
| FDA-2009-E-0087-0013 | FDA | Patent Term Extension Application for CONVENIA® (Cefovecin Sodium), U.S. Patent No. 6,020,329 FDA-2009-E-0087 | U.S. Patent and Trademark Office to Zoetis - Letter | Other | Letter(s) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T13:04:38Z | 0 | 0 | 09000064814d407b | ||
| FDA-2013-V-1559-0002 | FDA | Laser Light Show FDA-2013-V-1559 | Acknowledgement Letter to Coast Digital Solutions, Inc. | Other | Acknowledgement Letter/Receipt | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T18:13:20Z | 0 | 0 | 09000064814a5fa4 | ||
| FDA-2013-N-1563-0001 | FDA | Appendix 4 to Draft Qualitative Risk Assessment of Risk of Activity/Food Combinations for Activities (Outside the Farm Definition) Conducted in a Facility Co-Located on a Farm; Availability FDA-2013-N-1563 | Appendix 4 to Draft Qualitative Risk Assessment of Risk of Activity/Food Combinations for Activities (Outside the Farm Definition) Conducted in a Facility Co-Located on a Farm; Availability | Proposed Rule | Request for Comment | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2014-04-01T03:59:59Z | 2014-01-01T02:04:13Z | 2013-30375 | 0 | 0 | 09000064814d536f |
| FDA-2013-V-1559-0001 | FDA | Laser Light Show FDA-2013-V-1559 | Coast Digital Solutions, Inc. - Application for Variance | Other | Application for Variance (VAR) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T18:13:19Z | 0 | 0 | 09000064814a5f9f | ||
| FDA-2013-E-0682-0004 | FDA | Patent Term Extension Application for, Zilver-PTX Drug Eluting Peripheral Stent, U.S. Patent No. 5,616,608 FDA-2013-E-0682 | U.S. Patent and Trademark Office to Venable LLP - Letter | Other | Letter(s) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T13:23:43Z | 0 | 0 | 09000064814d407d | ||
| FDA-2013-N-1496-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Generic Rapid Response Surveys FDA-2013-N-1496 | Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Rapid Response Surveys (Generic Clearance) | Notice | General Notice | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2014-02-25T04:59:59Z | 2013-12-24T15:06:13Z | 2013-30630 | 0 | 0 | 09000064814d55d8 |
| FDA-2013-V-1560-0002 | FDA | Laser Light Show FDA-2013-V-1560 | Acknowledgement Letter to Davaine Lighting | Other | Acknowledgement Letter/Receipt | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T18:19:41Z | 0 | 0 | 09000064814a5c89 | ||
| FDA-2013-V-1560-0001 | FDA | Laser Light Show FDA-2013-V-1560 | Davaine Lighting - Application for Variance | Other | Application for Variance (VAR) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T18:19:25Z | 0 | 0 | 09000064814a5c85 | ||
| FDA-2013-P-0380-0003 | FDA | Regarding Removal of the Black Box Warning on Package Labeling for the Injectable Contraceptive Depot Medroxyprogesterone Acetate (DMPA) FDA-2013-P-0380 | FDA/CDER Interim Response to the University of Florida College of Medicine - Jacksonville and the UNC School of Medicine - Letter | Other | Letter(s) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2015-07-07T22:14:36Z | 0 | 0 | 09000064814414e8 | ||
| FDA-2011-P-0086-0006 | FDA | Asking FDA to Adopt and Apply Specific Bioequivalence Requirements in its Review of Proposed Follow-on Version of RISPERDAL® CONSTA® FDA-2011-P-0086 | Janssen Research & Development, LLC. - Supplement | Other | Supplement (SUP) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T20:07:39Z | 0 | 0 | 09000064814ba9d1 | ||
| FDA-2012-N-0284-0009 | FDA | Pediatric Studies of Sodium Nitroprusside Conducted in Accordance with Section 409 I of the Public Health Service Act-CLOSED FDA-2012-N-0284 | FDA CDER Memorandum December 17 2013 re for use of Sodium Nitroprusside to Reduce Blood Pressure in Pediatric Patients | Other | Memorandum | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T13:59:09Z | 0 | 0 | 09000064814d51b8 | ||
| FDA-2013-N-1425-0001 | FDA | Focused Mitigation Strategies to Protect Food Against Intentional Adulteration FDA-2013-N-1425 | Focused Mitigation Strategies To Protect Food Against Intentional Adulteration; Public Meeting on Proposed Rule | Proposed Rule | Public Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T15:38:06Z | 2013-30372 | 0 | 0 | 09000064814d54bf | |
| FDA-2013-N-0001-0115 | FDA | Advisory Committee, Workshops & Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc) FDA-2013-N-0001 | Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T14:49:23Z | 2013-30579 | 0 | 0 | 09000064814d52cb | |
| FDA-2013-N-1425-0002 | FDA | Focused Mitigation Strategies to Protect Food Against Intentional Adulteration FDA-2013-N-1425 | Focused Mitigation Strategies to Protect Food Against Intentional Adulteration | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2014-04-01T03:59:59Z | 2014-04-04T01:02:32Z | 2013-30373 | 0 | 0 | 09000064814d53fc |
| FDA-2013-N-0001-0116 | FDA | Advisory Committee, Workshops & Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc) FDA-2013-N-0001 | Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T14:52:21Z | 2013-30580 | 0 | 0 | 09000064814d531a |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;